Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/18/26 | 8-K/A | Current report |
|
  |
324 |
| 02/17/26 | SCHEDULE 13G | Statement of Beneficial Ownership by Certain Investors |
|
6 | |
| 02/12/26 | 424B3 | Prospectus [Rule 424(b)(3)] |
|
40 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
